1.  13
    Device Representatives in Hospitals: Are Commercial Imperatives Driving Clinical Decision-Making?Quinn Grundy, Katrina Hutchison, Jane Johnson, Brette Blakely, Robyn Clay-Wlliams, Bernadette Richards & Wendy A. Rogers - 2018 - Journal of Medical Ethics 44 (9):589-592.
    Despite concerns about the relationships between health professionals and the medical device industry, the issue has received relatively little attention. Prevalence data are lacking; however, qualitative and survey research suggest device industry representatives, who are commonly present in clinical settings, play a key role in these relationships. Representatives, who are technical product specialists and not necessarily medically trained, may attend surgeries on a daily basis and be available to health professionals 24 hours a day, 7 days a week, to provide (...)
    Direct download (5 more)  
    Export citation  
    Bookmark   2 citations  
  2.  21
    Health Professionals “Make Their Choice”: Pharmaceutical Industry Leaders’ Understandings of Conflict of Interest.Quinn Grundy, Lisa Tierney, Christopher Mayes & Wendy Lipworth - 2017 - Journal of Bioethical Inquiry 14 (4):541-553.
    Conflicts of interest, stemming from relationships between health professionals and the pharmaceutical industry, remain a highly divisive and inflammatory issue in healthcare. Given that most jurisdictions rely on industry to self-regulate with respect to its interactions with health professionals, it is surprising that little research has explored industry leaders’ understandings of conflicts of interest. Drawing from in-depth interviews with ten pharmaceutical industry leaders based in Australia, we explore the normalized and structural management of conflicts of interest within pharmaceutical companies. We (...)
    Direct download (3 more)  
    Export citation  
    Bookmark   1 citation  
  3. A Politics of Objectivity: Biomedicine’s Attempts to Grapple with “Non-Financial” Conflicts of Interest.Quinn Grundy - 2021 - Science and Engineering Ethics 27 (3):1-18.
    Increasingly, policymakers within biomedicine argue that “non-financial” interests should be given equal scrutiny to individuals’ financial relationships with industry. Problematized as “non-financial conflicts of interest,” interests, ranging from intellectual commitments to personal beliefs, are managed through disclosure, restrictions on participation, and recusal where necessary. “Non-financial” interests, though vaguely and variably defined, are characterized as important influences on judgment and thus, are considered risks to scientific objectivity. This article explores the ways that “non-financial interests” have been constructed as an ethical problem (...)
    No categories
    Direct download (2 more)  
    Export citation